
58.89 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 49.24 Today|||52-Week Range 85.70 | -11.84% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $1.0B |
Ligand Pharmaceuticals, Inc. 3911 Sorrento Valley Boulevard San Diego California 92121 |
Todd C. Davis | Chief Executive Officer & Director |
Matthew Edward Korenberg | President & Chief Operating Officer |
Octavio Espinoza | Chief Financial Officer |
Simon Latimer | Investors Relations Manager |
Audrey Warfield-Graham | Chief People Officer |